Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 24.08.2026 1 Am J Pathol 1 Ann Oncol 4 Ann Surg Oncol 2 BMC Cancer 2 Br J Cancer 1 Breast Cancer 1 Breast Cancer Res 1 Breast Cancer Res Treat 1 Breast J 1 Cancer 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 4 Clin Breast Cancer 2 Clin Exp Metastasis 1 Int J Cancer 1 Int J Oncol 3 Int J Radiat Oncol Biol Phys 1 J Clin Invest 1 J Clin Oncol 2 J Natl Cancer Inst 4 Lancet 3 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiol Imaging Cancer 2 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. SATI DM, Shinde VD, Agarwal C
   Refining Spatial Transcriptomic Insights into Obesity-Driven Breast Cancer Biology Beyond Body Mass Index.
   Am J Pathol. 2026;196:2022-2023.
   PubMed        
   
   

   
   Ann Oncol

2. KALINSKY K, Barlow WE, Pathak HB, Puri RV, et al
   Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
   Ann Oncol. 2026;37:1220-1229.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. LEGALL C, Darrigues L, Sabah J, Hamy AS, et al
   Impact of Tumor Size on Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
   Ann Surg Oncol. 2026 Aug 21. doi: 10.1245/s10434-026-20307.
   PubMed         Abstract available
   
   
4. XIA LY, Cao XC, Hu QL
   Discordance between Breast and Axillary Responses After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Implications for Surgical De-Escalation.
   Ann Surg Oncol. 2026 Aug 20. doi: 10.1245/s10434-026-20437.
   PubMed         Abstract available
   
   
5. PITSINIS V, Khitab N, Jordan L, Vinci A, et al
   ASO Author Reflections: From Feasibility to Implementation: Establishing Indocyanine Green as a Single-Tracer Strategy for Sentinel Lymph Node Biopsy in Breast Cancer.
   Ann Surg Oncol. 2026 Aug 19. doi: 10.1245/s10434-026-20444.
   PubMed        
   
   
6. BECK AC, Carroll EF, Mukhtar RA, Cassidy MR, et al
   Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal.
   Ann Surg Oncol. 2026 Aug 17. doi: 10.1245/s10434-026-20368.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. SARATHCHANDRA S, Fittipaldi C, Alamukii NA, Kovacs A, et al
   Spheroid cultures reveal cancer stem cell enrichment and distinct chemotherapeutic response in triple-negative breast cancer.
   BMC Cancer. 2026;26:994.
   PubMed         Abstract available
   
   
8. HOUGHTON LC, Ganmaa D, Dos Santos Silva I, Falk R, et al
   Estrogen metabolites in premenopausal women living in China, Mongolia, and the United Kingdom.
   BMC Cancer. 2026;26:1000.
   PubMed         Abstract available
   
   

   
   Br J Cancer

9. HANIF SZ, Kutz C, Au CC, Torregroza I, et al
   Role of orphan G protein-coupled receptor GPR52 in breast cancer cell multicellular organization and collective invasion.
   Br J Cancer. 2026 Aug 20. doi: 10.1038/s41416-026-03565.
   PubMed         Abstract available
   
   
10. ARMSTRONG A, Heng YJ, Sardella BR, Ratcliffe M, et al
    Associations of alcohol use with expression of stromal markers in benign breast biopsy samples.
    Br J Cancer. 2026;135:784-790.
    PubMed         Abstract available
    
    

    
    Breast Cancer

11. KOIZUMI K, Igarashi A, Gouldson M, Bilthare S, et al
    Correction: Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score((R)) test among node-negative early breast cancer patients in Japan.
    Breast Cancer. 2026 Aug 21. doi: 10.1007/s12282-026-01905.
    PubMed        
    
    

    
    Breast Cancer Res

12. BADAWY W
    Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH).
    Breast Cancer Res. 2026;28:146.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

13. SANTEN RJ, Demers LM
    History of the early development of aromatase inhibitors for treatment of breast cancer.
    Breast Cancer Res Treat. 2026;219:1.
    PubMed         Abstract available
    
    

    
    Breast J

14. CHEN L, Du Y, Liu W
    Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules.
    Breast J. 2026;2026:e2642494.
    PubMed         Abstract available
    
    

    
    Cancer

15. GATCOMBE H, Graziani DS, Kristoff T, Arciero C, et al
    Top advances of the year: Breast cancer.
    Cancer. 2026;132:e70572.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

16. SATTAYAPIWAT O, Weaver DL, Borowsky AD, Keegan THM, et al
    Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available
    
    

    
    Cancer Lett

17. ZHAO Z, Zheng ZY, Lei JT, Baik MJ, et al
    Corrigendum to "NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis" [Cancer Lett. 655 (2026) 218636].
    Cancer Lett. 2026 Aug 17:218776. doi: 10.1016/j.canlet.2026.218776.
    PubMed        
    
    

    
    Clin Breast Cancer

18. BACLIG NV, Chengappa M, Soliman AJ, Jacob S, et al
    Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2026;26:91-100.
    PubMed         Abstract available
    
    
19. GUNEY B, Han O, Sagir S, Cakir Guney B, et al
    Dynamic Changes in NPAR and the CALLY Score for Predicting Pathological Complete Response in Breast Cancer: A Simple Combined Clinical Score.
    Clin Breast Cancer. 2026;26:114-120.
    PubMed         Abstract available
    
    
20. JAVED R, Veli M, De Souza K, Fessas P, et al
    Impact of Immunotherapy Addition on Dose Density and Clinical Outcomes of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Retrospective, Real-world Study From Multiple Centers in London, UK.
    Clin Breast Cancer. 2026;26:107-113.
    PubMed         Abstract available
    
    
21. YAO AL, Ward RC, Dibble EH
    Cryoablation Within the Evolving Paradigm of Multidisciplinary Breast Cancer Treatment De-Escalation.
    Clin Breast Cancer. 2026;26:84-90.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

22. HANSSON E, Sunden M, Wadsten C, Rask G, et al
    Correction: Breast cancer liver metastases and the impact of receptor expression on survival.
    Clin Exp Metastasis. 2026;43:42.
    PubMed        
    
    
23. WAN X, Zhao X, Lin Y, Yang S, et al
    THBS2: the key hub linking breast cancer stroma, immunity, and therapeutic response.
    Clin Exp Metastasis. 2026;43:41.
    PubMed         Abstract available
    
    

    
    Int J Cancer

24. WU J, Liu D, Chen M, Lin C, et al
    Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal Breast Cancer: A Single-Arm Clinical Trial.
    Int J Cancer. 2026 Aug 17. doi: 10.1002/ijc.70666.
    PubMed         Abstract available
    
    

    
    Int J Oncol

25. PAN T, Feng Z, Shang T, Jiang J, et al
    Single in situ intratumoral low?dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune?cold triple?negative breast cancer.
    Int J Oncol. 2026;69:117.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

26. FEDE F, Tessonnier T, Filosa DI, Formicola E, et al
    Radiobiological and Treatment Planning Evidence Supporting Particle Therapy in Aggressive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2026 Aug 17:S0360-3016(26)04140.
    PubMed         Abstract available
    
    
27. MACDONALD SM, Kirova Y, Campbell L, Jimenez R, et al
    Proton Radiation for Locally Advanced Breast Cancer: Evolution and Techniques.
    Int J Radiat Oncol Biol Phys. 2026 Aug 19:S0360-3016(26)04195.
    PubMed         Abstract available
    
    
28. PENG Y, Zhang S, Tie J, Xiang Y, et al
    MRI-Based Internal Mammary Node Response After Neoadjuvant Therapy to Guide Postoperative Internal Mammary Node Radiotherapy Boost in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2026 Aug 21:S0360-3016(26)04208.
    PubMed         Abstract available
    
    

    
    J Clin Invest

29. TU X, Zeng X, Sun Y, Ouyang Y, et al
    ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression.
    J Clin Invest. 2026;136:e192285.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

30. TUNG N, Zhao F, DeMichele A, Prat A, et al
    Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2?Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
    J Clin Oncol. 2026 Aug 20:JCO2502255. doi: 10.1200/JCO-25-02255.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

31. LAPIDARI P, Lustberg M, Havas J, Pagliuca M, et al
    Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.
    J Natl Cancer Inst. 2026 Aug 18:djag280. doi: 10.1093.
    PubMed         Abstract available
    
    
32. MASSA D, Chiappe E, Delucchi V, Girardi F, et al
    Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.
    J Natl Cancer Inst. 2026 Aug 18:djag281. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet

33. MACIOS A, Bretthauer M, Kalager M
    Adjunctive ultrasonography in breast cancer screening: the J-START trial.
    Lancet. 2026;408:696.
    PubMed        
    
    
34. JING S, Song J
    Adjunctive ultrasonography in breast cancer screening: the J-START trial.
    Lancet. 2026;408:696-697.
    PubMed        
    
    
35. FUSHIMI A
    Adjunctive ultrasonography in breast cancer screening: the J-START trial.
    Lancet. 2026;408:697.
    PubMed        
    
    
36. HARADA-SHOJI N, Suzuki A, Ishida T, Yamamoto S, et al
    Adjunctive ultrasonography in breast cancer screening: the J-START trial - Authors' reply.
    Lancet. 2026;408:697-698.
    PubMed        
    
    

    
    PLoS One

37. 
    Expression of Concern: Genome-wide miRNA response to anacardic acid in breast cancer cells.
    PLoS One. 2026;21:e0356341.
    PubMed        
    
    
38. STRACKE C, Kautz-Freimuth S, Shukri A, Isselhard A, et al
    Decision coaching for healthy women with BRCA1/2 pathogenic variants and open family planning: Impact on decisional conflict and decision status: Subgroup analyses from a randomized controlled trial.
    PLoS One. 2026;21:e0354884.
    PubMed         Abstract available
    
    
39. WOOF VG, Valasaki M, Stutzin Donoso F, McWilliams L, et al
    Acceptability of breast cancer risk assessment for women aged 30-49: Views of women from six under-served groups.
    PLoS One. 2026;21:e0356263.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

40. 
    Correction for Yang et al., Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression.
    Proc Natl Acad Sci U S A. 2026;123:e2626420123.
    PubMed        
    
    

    
    Radiol Imaging Cancer

41. HU C
    Pixels to Prognosis: Translating Synthetic MRI Radiomics into Clinical Practice for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    Radiol Imaging Cancer. 2026;8:e260448.
    PubMed        
    
    

    
    Radiother Oncol

42. VIANI GA, Arruda CV, Hamamura AC, Cardoso CE, et al
    Preoperative stereotactic body radiotherapy for early-stage luminal breast cancer: a systematic review and meta-analysis (PRELUMEN).
    Radiother Oncol. 2026 Aug 15:111743. doi: 10.1016/j.radonc.2026.111743.
    PubMed         Abstract available
    
    
43. CATALANO A, Materne S, Badenchini F, Gioscio E, et al
    Microvascular health status as a novel predictor of acute side effects after radiotherapy: a quantitative analysis across three cancer sites.
    Radiother Oncol. 2026;222:111693.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum